Rose |
|
Basic Information
Biological name (genus and species):
Rosa
Parts used for medicinal purposes:
Berries/fruits
Petals/flower
Chemicals this herb contains:
Ascorbic acid
Cyanogenic glycoside (See Glossary)
Quercitrin
Tannins (See Glossary)
Vitamins A and C
Volatile oils (See Glossary)
KNOWN EFFECTS
Shrinks tissues.
Prevents secretion of fluids.
Interferes with absorption of iron and other minerals when
taken internally.
Miscellaneous information:
North-American Indians formerly used fruit as a food source.
Leaves are used to make tea or salads and smoked like tobacco.
Rose hips used in vitamin-C supplements.
Adds flavor to foods during cooking.
UNPROVED SPECULATED BENEFITS
None.
WARNINGS AND PRECAUTIONS
Don't take if you:
Are pregnant, think you may be pregnant or plan pregnancy in
the near future.
Consult your doctor if you:
No contraindications if you are not pregnant and do not take
amounts larger than manufacturer's recommended dosage.
Pregnancy:
Problems in pregnant women taking small or usual amounts have
not been proved. But the chance of problems does exist. Don't
use unless prescribed by your doctor.
Breast-feeding:
Problems in breast-fed infants of lactating mothers taking
small or usual amounts have not been proved. But the chance of
problems does exist. Don't use unless prescribed by your doctor.
Infants and children:
Treating infants and children under 2 with any herbal
preparation is hazardous.
Others:
None expected if you are beyond childhood and under 45,
basically healthy and take for only a short time.
Storage:
Keep cool and dry, but don't freeze. Store safely away from
children.
Safe dosage:
At present no "safe" dosage has been established.
TOXICITY
Comparative-toxicity rating not available from standard
references.
ADVERSE REACTIONS, SIDE EFFECTS OR OVERDOSE SYMPTOMS
None expected
|
|
|
|
Dserun mollit anim id est laborum. Lorem ipsum and sunt in culpa qui officias deserunt mollit. Excepteur plus sint occaecat the best cupidatat nonr proident, sunt in culpa qui officia deserunt mollit anim id est laborum. September 24, 2004
